397 related articles for article (PubMed ID: 32844349)
1. Radiomics in Hepatocellular Carcinoma.
Sagir Kahraman A
J Gastrointest Cancer; 2020 Dec; 51(4):1165-1168. PubMed ID: 32844349
[TBL] [Abstract][Full Text] [Related]
2. Radiomics, Radiogenomics, and Next-Generation Molecular Imaging to Augment Diagnosis of Hepatocellular Carcinoma.
Bell M; Turkbey EB; Escorcia FE
Cancer J; 2020; 26(2):108-115. PubMed ID: 32205534
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of
Lee SM; Kim HS; Lee S; Lee JW
World J Gastroenterol; 2019 Mar; 25(11):1289-1306. PubMed ID: 30918424
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?
Hesketh RL; Zhu AX; Oklu R
Am J Clin Oncol; 2015 Aug; 38(4):431-6. PubMed ID: 25238287
[TBL] [Abstract][Full Text] [Related]
5. HCC and Tumor Biomarkers: Does One Size Fits All?
Ozgor D; Otan E
J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
[TBL] [Abstract][Full Text] [Related]
6. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint.
Karadag Soylu N
J Gastrointest Cancer; 2020 Dec; 51(4):1176-1186. PubMed ID: 32844348
[TBL] [Abstract][Full Text] [Related]
7. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
[TBL] [Abstract][Full Text] [Related]
8. [Research progress of radiomics with artificial intelligence in precise diagnosis and treatment of hepatocellular carcinoma].
Li YH; Jia WD
Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):905-909. PubMed ID: 33256273
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
[TBL] [Abstract][Full Text] [Related]
10. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
Wei J; Jiang H; Zhou Y; Tian J; Furtado FS; Catalano OA
Dig Liver Dis; 2023 Jul; 55(7):833-847. PubMed ID: 36641292
[TBL] [Abstract][Full Text] [Related]
11. Radiomics and radiogenomics of primary liver cancers.
Jeong WK; Jamshidi N; Felker ER; Raman SS; Lu DS
Clin Mol Hepatol; 2019 Mar; 25(1):21-29. PubMed ID: 30441889
[TBL] [Abstract][Full Text] [Related]
12. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
[TBL] [Abstract][Full Text] [Related]
13. Role of [
Ye YF; Wang W; Wang T; Yu J; Geng L; Yu SF; Yan S; Zheng SS
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):257-263. PubMed ID: 28603093
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
15. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
16. Current management of hepatocellular carcinoma.
Mendizabal M; Reddy KR
Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
[TBL] [Abstract][Full Text] [Related]
17. Reinventing radiation therapy with machine learning and imaging bio-markers (radiomics): State-of-the-art, challenges and perspectives.
Dercle L; Henry T; Carré A; Paragios N; Deutsch E; Robert C
Methods; 2021 Apr; 188():44-60. PubMed ID: 32697964
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma.
Chalaye J; Costentin CE; Luciani A; Amaddeo G; Ganne-Carrié N; Baranes L; Allaire M; Calderaro J; Azoulay D; Nahon P; Seror O; Mallat A; Soussan M; Duvoux C; Itti E; Nault JC
J Hepatol; 2018 Aug; 69(2):336-344. PubMed ID: 29518452
[TBL] [Abstract][Full Text] [Related]
19. Radiomic Features at Contrast-enhanced CT Predict Recurrence in Early Stage Hepatocellular Carcinoma: A Multi-Institutional Study.
Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
Radiology; 2020 Mar; 294(3):568-579. PubMed ID: 31934830
[TBL] [Abstract][Full Text] [Related]
20. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma.
Hectors SJ; Lewis S; Besa C; King MJ; Said D; Putra J; Ward S; Higashi T; Thung S; Yao S; Laface I; Schwartz M; Gnjatic S; Merad M; Hoshida Y; Taouli B
Eur Radiol; 2020 Jul; 30(7):3759-3769. PubMed ID: 32086577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
